Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312960 (3-[1-(2,3-Difluoro-4-methylbenzyl)-5-fluoro-6-meth...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet  | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.25 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312961 (3-[1-(2,3-Difluoro-4-methylbenzyl)-6-methyl-1H-pyr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.650 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312944 (3-[5-Fluoro-1-(2-fluoro-4-methylbenzyl)-6-methyl-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312945 (3-[1-(2-Fluoro-4-methylbenzyl)-6-methyl-1H-pyrazol...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312965 (3′-[1-(2,3-Difluoro-4-methylbenzyl)-6-methyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312950 (3-[1-(4-Chloro-2-fluorobenzyl)-6-methyl-1H-pyrazol...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312933 ( 3-[1-(2,3-Difluorobenzyl)-5-fluoro-6-methyl-1H-py...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312942 (Sodium 3-[1-(2,3-difluorobenzyl)-5-fluoro-6-methyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312948 (3-[1-(4-Chloro-2-fluorobenzyl)-5-fluoro-6-methyl-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312958 (3-[5-Fluoro-1-(3-fluoro-4-methylbenzyl)-6-methyl-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312959 (3-[1-(3-Fluoro-4-methylbenzyl)-6-methyl-1H-pyrazol...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312962 (3′-[1-(2-Fluoro-4-methylbenzyl)-6-methyl-1H-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312952 (7,7-Dimethyl-3-[6-methyl-1-(2,3,6-trifluorobenzyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312946 (3-[1-(2,4-Difluorobenzyl)-5-fluoro-6-methyl-1H-pyr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312963 (3′-[1-(2,3-Difluorobenzyl)-6-methyl-1H-pyraz...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312957 (3-[1-(2,6-Difluorobenzyl)-6-methyl-1H-pyrazolo[3,4...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312951 (3-[5-Fluoro-6-methyl-1-(2,3,6-trifluorobenzyl)-1H-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312947 (3-[1-(2,4-Difluorobenzyl)-6-methyl-1H-pyrazolo[3,4...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312953 (3-[1-(3-Chloro-2-fluorobenzyl)-5-fluoro-6-methyl-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312955 (3-[1-(3-Chloro-2-fluorobenzyl)-6-methyl-1H-pyrazol...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM312956 (3-[1-(2,6-Difluorobenzyl)-5-fluoro-6-methyl-1H-pyr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description To determine their in vitro action on human PDE 5, the test substances are dissolved in 100% DMSO and serially diluted. Typically, dilution series (1... | US Patent US9605008 (2017) BindingDB Entry DOI: 10.7270/Q2DZ0BC2 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
